eli lilly sues compounders for selling unauthorized tirzepatide copies Lilly, Novo Fight Weight Loss Drug Over Shortage Legal Action by Eli Lilly

Clin Biochem

[5] [9] Zepbound was subsequently approved in November 2023 for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, or obstructive sleep apnea

For those navigating this landscape, the key is making the best decision with the information and options available today, while staying informed about what is coming

What Caused the GLP-1 Medication Shortage The initial GLP-1 shortage emerged when branded semaglutide and tirzepatide prescriptions skyrocketed beyond manufacturing capacity

It catches concentration mix-ups, arithmetic errors, syringe misreads, and dose escalation mistakes

Although all of these natural alternatives to metformin seem to positively affect glycemic control, remember that none are a substitute for a medication your doctor has prescribed